País: Canadá
Idioma: inglés
Fuente: Health Canada
DEXMEDETOMIDINE HYDROCHLORIDE
ORION CORPORATION
0.5MG
SOLUTION
DEXMEDETOMIDINE HYDROCHLORIDE 0.5MG
INTRAMUSCULAR
10ML
Prescription
CATS; DOGS
Active ingredient group (AIG) number: 0152657001
APPROVED
2009-09-28
02 APR 2015 11:21 PROFILE DEXDOMITOR ® DIN 02333929 dexmedetomidine hydrochloride sterile injectable solution Veterinary Use Only Sedative and Analgesic For cats and dogs DESCRIPTION: Dexdomitor ® (dexmedetomidine hydrochloride) is a synthetic alpha 2 -adrenoreceptor agonist with sedative and analgesic properties. The chemical name is (+)-4- [(S)- α , 2,3-trimethylbenzyl]imidazole hydrochloride. It is a white, or almost white, crystalline, water soluble substance having a molecular weight of 236.7. The molecular formula is C 13 H 16 N 2 •HCl and the structural formula is: Each mL of Dexdomitor Sterile Injectable Solution contains 0.5 mg dexmedetomidine hydrochloride, 1.6 mg methyl parahydroxybenzoate and 0.2 mg propyl parahydroxybenzoate as preservatives, 9.0 mg sodium chloride and water for injection. INDICATIONS: Dexdomitor Sterile Injectable Solution is indicated for use as a sedative and analgesic in dogs and cats to facilitate clinical examinations, clinical procedures, minor surgical procedures, and minor dental procedures. Dexdomitor Sterile Injectable Solution is also indicated for use as a preanesthetic to general anesthesia in dogs and cats. DOSAGE AND ADMINISTRATION: It is recommended that dogs and cats be fasted for 12 hours before treatment with Dexdomitor Sterile Injectable Solution. An eye lubricant should be applied to prevent corneal desiccation that may occur during sedation. Following injection of Dexdomitor Sterile Injectable Solution, the animal should be allowed to rest quietly for 15 minutes; sedation and analgesia occur within 5 to 15 minutes, with peak effects at 20 to 30 minutes after Dexdomitor Sterile Injectable Solution. _Dogs:_ Dexdomitor Sterile Injectable Solution produces sedation and analgesia when administered intramuscularly (IM) at a dose of 500 mcg/m 2 , or intravenously (IV) at a dose of 375 mcg/m 2 . Doses for preanesthesia are 125 or 375 mcg/m 2 IM. The choice of preanesthetic dose depends on the duration and severity of the procedure, as well as the anesthetic regime Leer el documento completo